NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) — TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), an explorer of lower-impact battery metals from seafloor polymetallic nodules, today announced that it has entered into a securities purchase agreement with certain investors for the purchase of 13,461,540 common shares
Nyxoah to Participate in the Oppenheimer 33rd Annual Healthcare Conference Mont-Saint-Guibert, Belgium – March 7, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today
Fourth quarter 2022 reported and adjusted EPS* were $1.71 and $1.65, respectively, compared to fourth quarter 2021 reported and adjusted EPS of $0.99 and $1.09 Full year 2022 reported and adjusted EPS* were $7.34 and $7.45, respectively, compared to full year 2021 reported and adjusted EPS of $1.73 and $6.67 In 2022,
BioXp™ 9600 system – a fully automated, high-throughput benchtop instrument for synthetic biology workflows – empowers scientists to accelerate discovery of new vaccines and biologics SAN DIEGO, Sept. 19, 2022 (GLOBE NEWSWIRE) — Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced commercial release
IEEE Task Force on Process Mining Steering Committee member joins mindzie as it aims to further expand the use cases and applications of process mining technology Julian Lebherz DALLAS, Aug. 30, 2022 (GLOBE NEWSWIRE) — mindzie, inc. (“mindzie“), provider of process mining and business process optimization software, today announced that
–6th Orphan Drug Designation granted to toripalimab in the US and EU SHANGHAI, China, July 21, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that toripalimab,
OKX is now available on TradingView OKX has partnered with TradingView to make it easy to go from charting to trading TradingView’s 30 million customers can now execute trades on OKX directly through TradingView Access to OKX offers TradingView users 640 more spot trading pairs and 100+ crypto derivatives, meeting
